Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Colthurst terminates license agreement with Hollis-Eden for HE-2000

Nov. 25, 1999

Pharmacokinetics of novel anti-HIV immunoconjugate in nonhuman primates and patients

Nov. 23, 1999

Myriad Genetics identifies new HIV drug target

Nov. 23, 1999

Prodrugs of AZT monophosphate evaluated for in vitro transepithelial transport, metabolism

Nov. 22, 1999

Potent and selective anti-HIV agents patented by French investigators

Nov. 22, 1999

AZT prodrug associated with increased exposure to AZT in pregnancy

Nov. 19, 1999

Apoptosis inhibitors from JT useful for HIV infection and hepatitis

Nov. 11, 1999

Remune increases lymphocyte proliferation in HIV infection

Nov. 5, 1999

FDA approves once-daily dosing for Videx tablets

Nov. 4, 1999

CMV retinitis in AIDS patients: HAART alone is effective

Nov. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....